Method and composition for inducing chondrogenesis or tenogenesis in mesenchymal stem cells
The current invention concerns a cell medium for in vitro inducing chondrogenesis or tenogenesis in mesenchymal stem cells (MSCs). The medium includes a glucose medium supplemented with at least one growth factor. The growth factor is selected from fibroblast growth factors (FGF) or transforming growth factors (TGF). FGF or TGF is present in a total concentration of between 1 and 15 ng/ml. In both cases, IGF can be added to enhance the induction process. In a further aspect, the invention provides for a use of such cell medium as well as a method for inducing isolated mesenchymal stem cells (MSCs) and a cell composition obtained by such method.
1. A method for inducing tenogenesis in isolated blood mesenchymal stem cells (MSCs), comprising culturing the MSCs in an inducing cell medium for a period of between 1 and 7 days to produce a population of tenogenic-induced cells, wherein said cell medium comprises a glucose medium supplemented with at least one growth factor, and wherein said growth factor is selected from fibroblast growth factors (FGF) or transforming growth factors (TGF), wherein said total FGF or total TGF is present in a concentration of between 1 and 15 ng/ml, and wherein said tenogenic-induced cells show an increase in collagen I expression of at least one and a half-fold and an increase in collagen III expression of at least eight-fold and a decrease in collagen II expression within a time span of 1 to 7 days, compared to non-induced cells.
2. The method according to claim 1 , wherein said medium comprises 5 ng/ml FGF-2.
3. The method according to claim 1 , wherein said MSCs are mammalian derived.
4. A method for inducing tenogenesis in isolated blood mesenchymal stem cells (MSCs), comprising:
culturing said MSCs in an inducing cell medium for a period of between 1 and 7 days to produce a population of tenogenic-induced cells,
wherein said medium comprises a glucose medium supplemented with at least one growth factor selected from the group consisting of a fibroblast growth factor (FGF) and a transforming growth factor (TGF),
wherein said FGF is selected from the group consisting of FGF-1, FGF-2, FGF-3, FGF-4, FGF-5, FGF-6, FGF-7, FGF-8, FGF-9, FGF-10, and combinations thereof,
wherein said TGF is selected from the group consisting of TGFα, TGFβ1, TGFβ2, TGFβ3, and combinations thereof,
wherein said total FGF, or total TGF, is present in a total concentration of between 1 and 15 ng/ml in said inducing cell medium, and
wherein said tenogenic-induced cells show an increase in collagen I expression of at least one and a half-fold and an increase in collagen III expression of at least eight-fold, and a decrease in collagen II expression, within a time span of 1 to 7 days as compared to non-induced cells.
5. The method according to claim 4 , wherein said total FGF or total TGF is present in a concentration of between 2 and 10 ng/ml.
6. The method according to claim 4 , wherein said medium further comprises insulin-like growth factor (IGF), selected from the group consisting of IGF-1, IGF-2, IGF-I, and combinations thereof in a concentration of between 10 and 225 ng/ml.
7. The method according to claim 4 , wherein said MSCs are seeded at a density of 2 to 30×10 3 MSCs/cm 2 .
8. The method according to claim 4 , wherein said mesenchymal stem cells are isolated from mammalian blood.